<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v7i4.2665</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v7i4.2665</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Risk Factors for Primary Failure of Arteriovenous Fistula in Chronic Kidney Disease Patients on Hemodialysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Anam</surname>
            <given-names>Namra</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hayat</surname>
            <given-names>Umar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Khurshid</surname>
            <given-names>Ahsan</given-names>
          </name>
          <email>ahsankhurshid737@gmail.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aamir</surname>
            <given-names>Muhammad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Quaid-e-Azam Medical College, Bahawalpur</institution>
        <country>Pakistan</country>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Ahsan Khurshid (ahsankhurshid737@gmail.com)</corresp>
        <fn fn-type="conflict">
          <p>The authors declare no conflict of interest.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-20">
        <day>20</day>
        <month>11</month>
        <year>2026</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2026</year>
      </pub-date>
      <volume>7</volume>
      <issue>4</issue>
      <fpage>326</fpage>
      <lpage>331</lpage>
      <history>
        <date date-type="received" iso-8601-date="2026-10-21">
          <day>21</day>
          <month>10</month>
          <year>2026</year>
        </date>
        <date date-type="accepted" iso-8601-date="2026-11-20">
          <day>20</day>
          <month>11</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2026 The Author(s)</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i4.2665" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i4.2665.pdf" content-type="application/pdf"/>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>To determine the factors that contribute to primary arteriovenous fistula failure in chronic kidney disease patients receiving hemodialysis.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>This case control study was carried out in the Department of Nephrology, Bahawal Victoria Hospital, Bahawalpur over six month period. 80 eligible patients with chronic kidney disease receiving hemodialysis were recruited after meeting the study inclusion criteria; 40 cases (with primary AVF failure) and 40 controls (without primary AVF failure). Basic demographic details such as age, gender, duration of CKD and duration since patient was on hemodialysis through AVF were noted. The risk factors in the form of diabetes mellitus, obesity, smoking, peripheral vascular disease (PVD) and type of AVF were noted.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Mean age of the study participants was 53.5 ± 12.1 years. There were 60% males. Female distribution was significantly higher (68.8%) in cases compared to controls (31.2%). Diabetes and PVD were significantly more common in cases (68.4%, 68.6%) compared to controls (31.6%, 31.4%). The cases had 3.7 (95% CI: 1.4-9.5) odds of being females, 4.3 (95% CI: 1.7-11.1, p-value 0.002) odds of being diabetics, 3.9 (95% CI: 1.55-10.1, p-value 0.003) odds of having PVD compared to controls.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our findings indicate that diabetes and female sex are the only independent risk factors for primary AVF failure.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Arteriovenous Fistula</kwd>
        <kwd>Factors</kwd>
        <kwd>Chronic Kidney Disease</kwd>
        <kwd>Failure</kwd>
        <kwd>Hemodialysis</kwd>
      </kwd-group>
      <funding-group>
        <funding-statement>This research received no specific grant from any funding agency.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Chronic kidney disease (CKD) is characterized by permanent renal parenchymal degradation and a steady loss in kidney function.1 Between 4.902 and 7.083 million people with CKD are thought to require renal replacement therapy.2 Despite significant medical and technical advancements in renal transplantation and peritoneal dialysis (PD), hemodialysis (HD) is still the backbone of care for these patients.3</p>
      <p>An arteriovenous fistula is a permanent form of vascular access used for hemodialysis, established from the natural blood channels.4 The forearm (radiocephalic) fistula is the most common site for arteriovenous fistula creation, although upper arm (brachiocephalic) fistulas may also be constructed.5 Arteriovenous fistulas (AVFs) have been shown to enhance hemodialysis patient’s survival when compared to central venous catheters (CVCs) for vascular access.6</p>
      <p>From all produced fistulae, 60% to 80% mature to an adequate AVF. The main reason for AVF primary failure is thrombosis. Moreover, it is the main reason for lost access indefinitely.7 Primary failure of AVF has been associated with several clinical factors, including age above 65 years, female sex, uremia, diabetes mellitus, PVD, and non-white ethnicity8</p>
      <p>In their study, Budak AB et al looked at 168 individuals with ESRD who were split into two groups: those who experienced early failure (n=46) and those who did not have any failure (n=122). It was shown that being a woman was a major risk factor for early failure of AVF (69.5% versus 36.1%; p=0.001). In the early failure group, there were substantially more patients with cephalic vein diameters less than 2 mm (78.3% versus 22.1%; p=0.028).9 The medical records of 178 patients with end-stage renal disease (ESRD) who had undergone arteriovenous fistula creation were reviewed by Gjorgjievski N et al, revealing 16.29% (29/178) of the produced fistulae experienced primary AVF failure, while 10.11% (18/178) experienced early thrombosis.10 Amadis MR and colleagues conducted a retrospective cohort study involving 225 arteriovenous fistulas created in 159 patients. AVF formation at the wrist showed a significantly higher early failure rate than AVF creation at the elbow (29.9% vs. 4.4%; p &lt; 0.001).11</p>
      <p>This study's objective is to assess the risk factors for primary AVF failure in hemodialysis patients in our community. In order to properly inform decision-making on vascular access, it is crucial to examine local rates of AVF primary failure and variables related with them. The results of our investigation would make it easier to develop regionally appropriate prediction algorithms for classifying patients into pertinent groups at risk for primary AVF maturation failure.</p>
    </sec>
    <sec>
      <title>Methodology</title>
      <p>This case control study was carried out in the department of Nephrology, Bahawal Victoria Hospital, Bahawalpur from 16th August 2025 to 15th January 2026. The sample size was estimated using the WHO calculator, keeping 5% level of significance, 80 % power of test, 69.5 % anticipated frequency of females in primary AVF failure group and 36.1 % anticipated frequency of females in non AVF failure group. 80 patients, aged between 18-70 years, of both genders, having chronic kidney disease and on hemodialysis through AVF for more than 3 months were selected and included in the study after informed consent. There were 40 cases (CKD patients on hemodialysis through AVF, and having primary failure of AVF), and 40 control (CKD patients on hemodialysis through AVF, not having primary AVF failure). Patients who underwent corrective AVF surgery and those not willing to participate in study were excluded. The demographic data including age, gender, duration of CKD and time since patient was on hemodialysis through AVF was noted. The risk factors in the form of diabetes mellitus, obesity, smoking, PVD and type of AVF were noted. All the data was recorded on a proforma.</p>
      <p>The data was analyzed through SPSS v. 25. The quantitative variables like age, duration of CKD and duration of hemodialysis through AVF were presented as mean and standard deviation. The qualitative variables like gender, diabetes mellitus, obesity, smoking, peripheral vascular disease and type of AVF were presented as frequency and percentages. Risk factors of primary AVF failure were assessed through logistic regression analysis. At first step, bivariate analysis was done and crude odds ratio with 95% confidence interval was reported. P-value for bivariate analysis was 0.20. Variables significant at bivariate analysis were entered in multivariable analysis for independent risk factors. Adjusted odds ratios with corresponding 95% confidence intervals were calculated, and p-value for multivariable analysis was 0.05.</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>Forty patients with primary AVF failure (cases) and forty without primary AVF (controls) were enrolled in the study. Mean age of the study participants was 53.5 ± 12.1 years. There were 60% (n=48) males in the study group. Mean duration of CKD was 3.9 ± 1.7 years and mean duration of hemodialysis through AVF was 11.2 ± 7.9 months. Radiocephalic type of AVF was most common (n=44, 55%) followed by brachiocephalic type in 37.5% (n=30). Age, duration of CKD, type of AVF and duration of hemodialysis did not differ significantly between case and controls. Female distribution was significantly higher (68.8%) in cases compared to controls (31.2%) [Table 1].</p>
      <table-wrap id="tbl1">
        <label>Table 1</label>
        <caption>
          <title>Demographic characteristics of CKD patients undergoing hemodialysis through AVF (N=80)</title>
        </caption>
        <table>
          <tbody>
            <tr>
              <td>Characteristics</td>
              <td>All (N=80)</td>
              <td>Cases (n=40)</td>
              <td>Controls (n=40)</td>
              <td>p-value*</td>
            </tr>
            <tr>
              <td>Age (years), mean ± SD</td>
              <td>53.5 ± 12.1</td>
              <td>53.8 ± 11.9</td>
              <td>53.2 ± 12.6</td>
              <td>0.820</td>
            </tr>
            <tr>
              <td>Gender, n(%)</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Male</td>
              <td>48 (60)</td>
              <td>18 (37.5)</td>
              <td>30 (62.5)</td>
              <td>0.006</td>
            </tr>
            <tr>
              <td>Female</td>
              <td>32 (40)</td>
              <td>22 (68.8)</td>
              <td>10 (31.2)</td>
              <td></td>
            </tr>
            <tr>
              <td>Duration (years) of CKD (mean ± SD)</td>
              <td>3.9 ± 1.7</td>
              <td>3.8 ± 1.6</td>
              <td>4.2 ± 1.8</td>
              <td>0.247</td>
            </tr>
            <tr>
              <td>Type of AVF, n(%)</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Radiocephalic</td>
              <td>44 (55)</td>
              <td>20 (45.5)</td>
              <td>24 (54.5)</td>
              <td>0.579</td>
            </tr>
            <tr>
              <td>Brachiocephalic</td>
              <td>30 (37.5)</td>
              <td>16 (53.3)</td>
              <td>14 (46.7)</td>
              <td></td>
            </tr>
            <tr>
              <td>Radiobasilic</td>
              <td>06 (7.5)</td>
              <td>04 (66.7)</td>
              <td>2 (33.3)</td>
              <td></td>
            </tr>
            <tr>
              <td>Duration (months) of hemodialysis (mean ± SD)</td>
              <td>11.2 ± 7.9</td>
              <td>11.4 ± 7.4</td>
              <td>10.9 ± 8.5</td>
              <td>0.759</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>“*Independent sample t-test for numerical data, chi-square test for qualitative data”</p>
      <p>There were 17.5% (n=14) obese participants, 47.5% (n=38) were diabetics, 32.5% (n=26) were smokers and 43.7% (n=35) had peripheral vascular disease. Diabetes was significantly more common in cases (68.4%) compared to controls (31.6%). Similarly, peripheral vascular disease was significantly more prevalent in cases (68.6%) compared to control (31.4%) [Table 2].</p>
      <table-wrap id="tbl2">
        <label>Table 2</label>
        <caption>
          <title>Distribution of co-morbid conditions in CKD patients undergoing hemodialysis through AVF (N=80)</title>
        </caption>
        <table>
          <tbody>
            <tr>
              <td>Co-morbidities</td>
              <td>All (N=80)</td>
              <td>Cases (n=40)</td>
              <td>Controls (n=40)</td>
              <td>p-value*</td>
            </tr>
            <tr>
              <td>Obesity</td>
              <td>Yes</td>
              <td>14 (17.5)</td>
              <td>04 (28.6)</td>
              <td>10 (71.4)</td>
              <td>0.139</td>
            </tr>
            <tr>
              <td></td>
              <td>No</td>
              <td>66 (82.5)</td>
              <td>36 (54.5)</td>
              <td>30 (45.5)</td>
              <td></td>
            </tr>
            <tr>
              <td>Diabetes mellitus</td>
              <td>Yes</td>
              <td>38 (47.5)</td>
              <td>26 (68.4)</td>
              <td>12 (31.6)</td>
              <td>0.002</td>
            </tr>
            <tr>
              <td></td>
              <td>No</td>
              <td>42 (52.5)</td>
              <td>14 (33.3)</td>
              <td>28 (66.7)</td>
              <td></td>
            </tr>
            <tr>
              <td>Smoking</td>
              <td>Yes</td>
              <td>26 (32.5)</td>
              <td>11 (42.3)</td>
              <td>15 (57.7)</td>
              <td>0.340</td>
            </tr>
            <tr>
              <td></td>
              <td>No</td>
              <td>54 (67.5)</td>
              <td>29 (53.7)</td>
              <td>25 (46.3)</td>
              <td></td>
            </tr>
            <tr>
              <td>Peripheral Vascular Disease</td>
              <td>Yes</td>
              <td>35 (43.7)</td>
              <td>24 (68.6)</td>
              <td>11 (31.4)</td>
              <td>0.003</td>
            </tr>
            <tr>
              <td></td>
              <td>No</td>
              <td>45 (56.3)</td>
              <td>16 (35.6)</td>
              <td>29 (64.4)</td>
              <td></td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>“*Chi-square test, Fischer’s exact test where cell count &lt; 5”</p>
      <p>The cases had 3.7 (95% CI: 1.4-9.5) odds of being females compared to controls. Cases had 4.3 (95% CI: 1.7-11.1, p-value 0.002) odds of being diabetics compared to controls. Cases had 3.9 (95% CI: 1.55-10.1, p-value 0.003) odds of having peripheral vascular disease compared to controls [Table 3].</p>
      <table-wrap id="tbl3">
        <label>Table 3</label>
        <caption>
          <title>Bivariate logistic regression analysis for risk factors of primary AVF failure in CKD patients undergoing hemodialysis through AVF (N=80)</title>
        </caption>
        <table>
          <tbody>
            <tr>
              <td>Factors</td>
              <td>Cases (n=40)</td>
              <td>Control (n=40)</td>
              <td>Crude Odds Ratio (95% CI)</td>
              <td>p-value*</td>
            </tr>
            <tr>
              <td>Age Groups</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Up to 50-year</td>
              <td>17 (43.6)</td>
              <td>22 (56.4)</td>
              <td>0.61 (0.25-1.46)</td>
              <td>0.263</td>
            </tr>
            <tr>
              <td>&gt; 50-year</td>
              <td>23 (56.1)</td>
              <td>18 (43.9)</td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Gender</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Female</td>
              <td>22 (68.8)</td>
              <td>10 (31.2)</td>
              <td>3.7 (1.4-9.5)</td>
              <td>0.007</td>
            </tr>
            <tr>
              <td>Male</td>
              <td>18 (37.5)</td>
              <td>30 (62.5)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Duration of CKD</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Up to 3-years</td>
              <td>22 (59.5)</td>
              <td>15 (40.5)</td>
              <td>2.04 (0.83-4.98)</td>
              <td>0.116</td>
            </tr>
            <tr>
              <td>&gt; 3-years</td>
              <td>18 (41.9)</td>
              <td>25 (58.1)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Duration of Dialysis through AVF</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Up to 10-months</td>
              <td>19 (44.2)</td>
              <td>24 (55.8)</td>
              <td>0.60 (0.25-1.46)</td>
              <td>0.262</td>
            </tr>
            <tr>
              <td>&gt; 10-months</td>
              <td>21 (56.8)</td>
              <td>16 (43.2)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Type of AVF</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Radiocephalic</td>
              <td>20 (45.5)</td>
              <td>24 (54.5)</td>
              <td>1 (Reference)</td>
              <td></td>
            </tr>
            <tr>
              <td>Brachiocephalic</td>
              <td>16 (53.3)</td>
              <td>14 (46.7)</td>
              <td>1.37 (0.54-3.48)</td>
              <td>0.506</td>
            </tr>
            <tr>
              <td>Radiobasilic</td>
              <td>4 (66.7)</td>
              <td>2 (33.3)</td>
              <td>2.4 (0.40-14.50)</td>
              <td>0.340</td>
            </tr>
            <tr>
              <td>Diabetes Mellitus</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>26 (68.4)</td>
              <td>12 (31.6)</td>
              <td>4.3 (1.7-11.1)</td>
              <td>0.002</td>
            </tr>
            <tr>
              <td>No</td>
              <td>14 (33.3)</td>
              <td>28 (66.7)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Smoking</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>11 (42.3)</td>
              <td>15 (57.7)</td>
              <td>0.63 (0.25-1.63)</td>
              <td>0.340</td>
            </tr>
            <tr>
              <td>No</td>
              <td>29 (53.7)</td>
              <td>25 (46.3)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Peripheral Vascular Disease</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>24 (68.6)</td>
              <td>11 (31.4)</td>
              <td>3.9 (1.55-10.1)</td>
              <td>0.003</td>
            </tr>
            <tr>
              <td>No</td>
              <td>16 (35.6)</td>
              <td>29 (64.4)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
            <tr>
              <td>Obesity</td>
              <td></td>
              <td></td>
              <td></td>
              <td></td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>04 (28.6)</td>
              <td>10 (71.4)</td>
              <td>0.33 (0.09-1.17)</td>
              <td>0.139</td>
            </tr>
            <tr>
              <td>No</td>
              <td>36 (54.5)</td>
              <td>30 (45.5)</td>
              <td>1 (Ref)</td>
              <td></td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>“*Chi-square test, Fischer’s exact test where cell count &lt; 5”</p>
      <p>After controlling for other demographic and comorbid conditions, presence of diabetes mellitus and female gender were the only independent risk factors of primary AVF failure in multivariable logistic regression analysis.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>In order to successfully create and mature AVF in patients with CKD, many disciplines must work together to address the fundamental reasons of failure. Although numerous studies have examined the pathophysiology and biomechanical factors involved in AVF maturation, the process remains complex and is not yet fully understood. The principal pathohistological alteration in the blood vessels that is linked to the initial failure of AVF has been identified as intimal hyperplasia.12 For patients who require a functional permanent vascular access for hemodialysis, the construction of an AVF is the initial step. In our study, the cases had 3.7 odds of being females, 4.3 odds of being diabetics and 3.9 odds of having peripheral vascular disease compared to controls. AVF patients who were recruited in a thorough follow-up program had an appropriate AVF maturation rate of 82% and a primary failure rate of 18%, according to Mc Lafferty et al, in 2007.13 Numerous researches have concentrated on the elements that indicate a functioning, effective AVF. From a total of 97 fistulae, Bashar et al, in 2015, reported 52 functionally developed fistula (53.60%). In their study, lower hemoglobin levels and female gender (p = 0.004), the use of calcium channel blockers at the time of AVF creation (p = 0.01), and a history of kidney transplantation (p = 0.036) were all significantly associated with AVF function.14 This does not relate to our observations where female gender was more associated with AVF failure. In comparison to men, Jemcov, in 2013, found that female gender was related with longer AVF development (OR 0.35, 95% CI = 0.17-0.72; p = 0.005).15 According to a 2010 study by Wasse et al, women were 36% less likely than men to utilize an AVF while starting hemodialysis.16 According to the Miller et al, in 2003, women were more likely than males to have a fistula in their upper arm as opposed to their forearm (64% vs. 36%).17 In our study, Radiocephalic type of AVF was most common (55%) followed by brachiocephalic type in 37.5% cases.</p>
      <p>In the study by Gjorgjievski et al., male patients were significantly more likely than female patients to undergo distal fistula formation (51 vs. 18; p = 0.015). The main failure of AVF was not substantially correlated with the quantity or location of AVF.10 Our study results also showed that age, duration of CKD, type of AVF and duration of hemodialysis did not differ significantly between case and controls. DM has been identified as the most prevalent cause of CKD, however unlike the other major renal illnesses, it was not linked to an undesirable result of fistula maturation during the first three years of its formation.18 According to Sedlacek et al's data from 2001, DM was not linked to adverse AVF maturation (67% of the diabetic group's AVFs matured compared to 62% of the non-diabetic group's). The prevalence of AVF genesis in patients was unaffected by DM as a condition.19 Kinnaert P et al discovered that women had a reduced chance of an AV fistula survival than males, which is consistent with our findings.20 A study by Ernandez T et al. identified distal AVF location, female gender, surgical expertise level and diabetes mellitus as significant predictors of early AVF failure.21 These findings are also relatable with our results.</p>
      <p>Age above 60 and the presence of peripheral vascular disease both substantially impacted fistula patency, according to a study by Field M et al (P=0.001 and P=0.048, respectively).22 An elevated risk of AVF failure has been connected to peripheral vascular disease. Small arteries like the radial artery at the wrist can have their intima media thickness (IMT) measured using modern high-frequency US scanners with high-resolution imaging capabilities.23 According to experts in the creation and management of permanent vascular access for hemodialysis, doppler ultrasonography plays a critical role in both preoperative vessel mapping to select suitable vessels for AVF creation and in the early detection of complications during postoperative surveillance. Silva et al's study from 1998, one of the early investigations, described the use of preoperative duplex imaging on forearm veins to pinpoint potential locations for AVF creation.24 When the internal diameter of the artery was less than 1.5 mm, Malovrh, in 1998, found that the likelihood of AVF failure rose, with a success rate of only 45%. His research showed that duplex sonography, a non-invasive technique, allowed for an adequate examination of the arteries prior to the development of an AVF.25</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>This study concludes that diabetes mellitus and female gender are the only independent risk factors for primary arteriovenous fistula failure. Factors contributing to AVF failure may differ across populations. Therefore, identifying local determinants of AVF failure and predictors of AVF patency is essential to support appropriate vascular access planning.</p>
      <p><bold>Ethical Approval: </bold>The IRB/EC approved this study via letter no. 569/DME/QAMC Bahawalpur dated January 21, 2026.</p>
      <p><bold>Conflict of Interest: </bold>   None</p>
      <p><bold>Funding Source: </bold>   None </p>
    </sec>
    <sec>
      <title>Authors’ Contribution</title>
      <p>NA: Conception.</p>
      <p>AK: Design of the work.</p>
      <p>UH, MA: Data acquisition, analysis, or interpretation.</p>
      <p>NA, UH, MA: Draft the work.</p>
      <p>AK: Review critically for important intellectual content.</p>
      <p>All authors approve the version to be published.</p>
      <p>All authors agree to be accountable for all aspects of the work.</p>
    </sec>
  </body>
  <back>
    <notes notes-type="author-contributions">
      <title>Author Contributions</title>
      <p>NA: Conception.</p>
      <p>AK: Design of the work.</p>
      <p>UH, MA: Data acquisition, analysis, or interpretation.</p>
      <p>NA, UH, MA: Draft the work.</p>
      <p>AK: Review critically for important intellectual content.</p>
      <p>All authors approve the version to be published.</p>
      <p>All authors agree to be accountable for all aspects of the work.</p>
    </notes>
    <notes notes-type="ethics-statement">
      <title>Ethics Statement</title>
      <p>yes. Ethics committee: Department of Medical Education, Quaid e Azam Medical College, Bahwalpur. Approval number: 569/DME/QAMC Bahawalpur.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Ammirati AL. Chronic kidney disease. Rev Assoc Méd Bras. 2020;66(Suppl 1):s03-9.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Renal Fibrosis: Mechanisms and Therapies. Adv Exp Med Biol. 2019;1165:3-15.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Shehzadi U, Akhtar N, Usman MA, Chaudhry A. Frequency of hemodialysis catheter related infectious complications in patients with end stage renal disease. Pak Armed Forces Med J. 2019;69(3):477-82.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Kirkham EN, Fallon J, Foy C, Harris S, Birch G, Bullingham J. Vessel diameter and close surveillance helps predict early patency in native arteriovenous fistulas. J Vasc Access. 2021:11297298211058034.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Gupta A, Kumar V, Peswani AR, Suresh A. Outcomes of arteriovenous fistula creation in patients undergoing hemodialysis: an 2022;14(1):e20921. Indian experience. Cureus.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Kim DH, Park JI, Lee JP, Kim YL, Kang SW. The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients. Ren Fail. 2020;42(1):30-9.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Mo H, Ahn S, Han A, Min S, Min SK, Jung IM. Outcome after early thrombotic occlusion of arteriovenous fistulas. J Vasc Access. 2022:11297298221076582.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Santosa R, Rustam R, Rivaldy V. Differences in arteriovenous fistula maturation between diabetes mellitus and non-diabetes mellitus in chronic renal failure patients in Padang. J Biomed Transl Res. 2022;6(1):1287-91.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Budak AB, Tonguc SA, Akalin N, Genctoy G. Prognostic factors for radiocephalic arteriovenous fistula maturation in patients with prior placement of a central venous catheter and relationship with 2020;11(3):124-32. inflammation. Turk J Clin Lab.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Gjorgjievski N, Dzekova-Vidimliski P, Gerasimovska V, Pavleska-Kuzmanovska S. Primary failure of the arteriovenous fistula in patients with chronic kidney disease stage 4/5. Open Access Maced J Med Sci. 2019;7(11):1782-7.</mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Amadis MR, Putranto JN, Maghfirah I, Mardiana N. Predictors of arteriovenous fistula early failure in end-stage renal disease patients: real-world data in Surabaya. IOP Conf Ser: Earth Environ Sci. 2020;441(1):012197.</mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Pushevski V, Dejanov P, Gerasimovska V, Petrushevska G, Oncevski A, Sikole A, et al. Severe endothelial damage in chronic kidney disease patients prior to haemodialysis vascular access surgery. Pril. 2015;36(3):43-9.</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>McLafferty RB, Pryor RW, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vasc Surg. 2007;45(5):981-5.</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Bashar K, Zafar A, Elsheikh S, Healy DA, Clarke-Moloney M, Casserly L, et al. Predictive parameters of arteriovenous fistula functional maturation in a population of patients with end-stage renal disease. PLoS One. 2015;10(3):e0119958.</mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation>Jemcov TK. Morphological and functional vessels characteristic by assessed by ultrasonography for prediction of arteriovenous fistula 2013;14(4):356-63. maturation. J Vasc Access.</mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation>Wasse H, Hopson DS, McClellan W. Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am J Nephrol. 2010;32(3):234-41.</mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation>Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int. 2003;63(1):346-52.</mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation>Polenakovic M, Sikole A, Nikolov IG, Georgiev D, Selim G, Dzekova-Vidimliski P, et al. Diabetics on dialysis in the Republic of Macedonia: A nationwide epidemiological study. Pril. 2010;31(1):261-77.</mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation>Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J Kidney Dis. 2001;38(3):560-564.</mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation>Kinnaert PP, Vereerstraeten P, Toussaint C, Van Geertruyden J. Nine years' experience with internal arteriovenous fistulas for haemodialysis: a study of some factors influencing the results. J Br Surg. 1977;64(4):242-6.</mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation>Ernandez T, Saudan P, Berney T, Merminod T, Bednarkiewicz M, Martin PY. Risk factors for early failure of native arteriovenous 2005;101(1):c39-44. fistulas. Nephron Clin Pract.</mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation>Field M, Van Dellen D, Mak D, Winter H, Hamsho A, Mellor S, et al. The brachiobasilic arteriovenous fistula: effect of patient variables. J Vasc Access. 2011;12(4):325-30.</mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation>Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistulas for dialysis access. J Vasc Surg. 2012;55(3):849-55.</mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation>Silva MB, Hobson RW, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of 98 preoperative noninvasive 1998;27(2):302-7. evaluation. J Vasc Surg.</mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <mixed-citation>Malovrh M. Non-invasive evaluation of vessels by duplex sonography prior to construction of arteriovenous fistulas for haemodialysis. Nephrol Dial Transplant. 1998;13(1):125-9.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
